If you made any changes in Pure these will be visible here soon.

Research Output 2008 2020

2020

Clinical features and treatment outcomes of limited-stage mantle cell lymphoma: Consortium for Improving Survival of Lymphoma report

and Consortium for Improving Survival of Lymphoma (CISL), 2020 Feb 1, In : Annals of Hematology. 99, 2, p. 223-228 6 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Lymphoma
Survival
Drug Therapy
Rare Diseases

Comparison between 5-day decitabine and 7-day azacitidine for lower-risk myelodysplastic syndromes with poor prognostic features: a retrospective multicentre cohort study

Lee, B. H., Kang, K. W., Jeon, M. J., Yu, E. S., Kim, D. S., Choi, H., Lee, S. R., Sung, H. J., Kim, B. S., Choi, C. W. & Park, Y., 2020 Dec 1, In : Scientific reports. 10, 1, 39.

Research output: Contribution to journalArticle

Open Access
decitabine
Azacitidine
Myelodysplastic Syndromes
Multicenter Studies
Cohort Studies

Correction to: Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores (Annals of Hematology, (2017), 96, 11, (1873-1881), 10.1007/s00277-017-3107-6)

Lee, H., Kim, Y. R., Kim, S. J., Park, Y., Eom, H. S., Oh, S. Y., Kim, H. J., Kang, H. J., Lee, W. S., Moon, J. H., Won, Y. W., Kim, T. S. & Kim, J. S., 2020 Jan 1, In : Annals of Hematology. 99, 1, 1 p.

Research output: Contribution to journalComment/debate

Open Access
Republic of Korea
Lymphoma, Large B-Cell, Diffuse
Hematology
Internal Medicine
Medicine
2019

Effect of Stem Cell Source and Dose on Allogeneic Hematopoietic Stem Cell Transplantation in Adult Patients with Idiopathic Aplastic Anemia: Data from the Korean Aplastic Anemia Trials

Kim, H., Lee, K. H., Sohn, S. K., Kim, I., Kim, S. H., Park, Y., Choi, J. H., Kwak, J. Y., Kim, M. K., Bae, S. H., Shin, H. J., Won, J. H., Lee, W. S. & Choi, Y., 2019 Jan 1, In : Acta Haematologica.

Research output: Contribution to journalArticle

Aplastic Anemia
Hematopoietic Stem Cell Transplantation
Stem Cells
Tissue Donors
Siblings

Modified dose of melphalan-prednisone in multiple myeloma patients receiving bortezomib plus melphalan-prednisone treatment

Lee, S. R., Choi, H., Lee, B. H., Kang, K. W., Yu, E. S., Kim, D. S., Park, Y., Choi, C. W., Kim, B. S. & Sung, H. J., 2019 Nov, In : Korean Journal of Internal Medicine. 34, 6, p. 1333-1346 14 p.

Research output: Contribution to journalArticle

Open Access
Melphalan
Prednisone
Multiple Myeloma
Disease-Free Survival
Therapeutics

MULTIPLE COLUMN CHROMATOGRAPHY AND METHOD FOR ISOLATING EXOSOMES

Park, Y. & Kim, H. K., 2019 May 14, Patent No. 10-1980482

Research output: Patent

Exosomes
Chromatography

Single-dose etoposide is an effective and safe protocol for stem cell mobilization in patients with multiple myeloma

Park, Y., Kim, D. S., Jeon, M. J., Lee, B. H., Yu, E. S., Kang, K. W., Lee, S. R., Sung, H. J., Nam, M-H., Yoon, S-Y., Choi, C. W., Kang, E. S., Cho, D., Kim, K., Kim, B. S., Kim, D. W. & Kim, S. J., 2019 Jan 1, In : Journal of Clinical Apheresis.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Mobilization
Etoposide
Multiple Myeloma
Stem Cell Transplantation
Blood Component Removal
1 Citation (Scopus)

Targeted sequencing aids in identifying clonality in chronic myelomonocytic leukemia

Hwang, S. M., Kim, S. M., Nam, Y., Kim, J., Kim, S., Ahn, Y. O., Park, Y., Yoon, S. S., Shin, S., Kwon, S. & Lee, D. S., 2019 Sep 1, In : Leukemia Research. 84, 106190.

Research output: Contribution to journalArticle

Leukemia, Myelomonocytic, Chronic
Mutation
Monocytes
Single-Cell Analysis
Neutrophils
2018
2 Citations (Scopus)

A risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score

Yhim, H. Y., Park, Y., Han, Y. H., Kim, S., Kang, S. R., Moon, J. H., Jeong, J. H., Shin, H. J., Kim, K., Choi, Y. S., Kim, K., Kim, M. K., Kong, E., Kim, D. S., Eo, J. S., Lee, J. H., Kang, D. Y., Lee, W. S., Lee, S. M., Do, Y. R. & 6 others, Ham, J. S., Kim, S. J., Kim, W. S., Choi, J. Y., Yang, D. H. & Kwak, J. Y., 2018 Dec 1, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2274-2284 11 p.

Research output: Contribution to journalArticle

Peripheral T-Cell Lymphoma
Neoplasms
Treatment Failure
Disease-Free Survival
Survival
1 Citation (Scopus)

Bendamustine plus rituximab for relapsed or refractory diffuse large B cell lymphoma: a multicenter retrospective analysis

Hong, J. Y., Yoon, D. H., Suh, C., Kim, W. S., Kim, S. J., Jo, J. C., Kim, J. S., Lee, W. S., Oh, S. Y., Park, Y., Kim, S. Y., Lee, M. H., Lee, H. S. & Do, Y. R., 2018 Apr 4, (Accepted/In press) In : Annals of Hematology. p. 1-7 7 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Intravenous Infusions
Confidence Intervals
Mantle-Cell Lymphoma
Febrile Neutropenia

Correction to: a risk stratification model for nodal peripheral T-cell lymphomas based on the NCCN-IPI and posttreatment Deauville score (European Journal of Nuclear Medicine and Molecular Imaging, (2018), 45, 13, (2274-2284), 10.1007/s00259-018-4093-1)

Yhim, H. Y., Park, Y., Han, Y. H., Kim, S., Kang, S. R., Moon, J. H., Jeong, J. H., Shin, H. J., Kim, K., Choi, Y. S., Kim, K., Kim, M. K., Kong, E., Kim, D. S., Eo, J. S., Lee, J. H., Kang, D. Y., Lee, W. S., Lee, S. M., Do, Y. R. & 6 others, Ham, J. S., Kim, S. J., Kim, W. S., Choi, J. Y., Yang, D. H. & Kwak, J. Y., 2018 Dec 1, In : European Journal of Nuclear Medicine and Molecular Imaging. 45, 13, p. 2482-2483 2 p.

Research output: Contribution to journalComment/debate

Peripheral T-Cell Lymphoma
Molecular Imaging
Nuclear Medicine
Treatment Failure

Lack of usefulness of computed tomography for surveillance in patients with aggressive non-Hodgkin lymphoma

Kang, K. W., Lee, S. R., Kim, D. S., Yu, E. S., Sung, H. J., Kim, S. J., Choi, C. W., Park, Y. & Kim, B. S., 2018 Feb 1, In : PLoS One. 13, 2, e0192656.

Research output: Contribution to journalArticle

non-Hodgkin lymphoma
computed tomography
Non-Hodgkin's Lymphoma
Tomography
relapse
3 Citations (Scopus)

Phase 2 Study of an Intravenous Busulfan and Melphalan Conditioning Regimen for Autologous Stem Cell Transplantation in Patients with Multiple Myeloma (KMM150)

Jung, S. H., Lee, J. J., Kim, J. S., Min, C. K., Kim, K., Choi, Y., Eom, H. S., Joo, Y. D., Kim, S. H., Kwak, J. Y., Kang, H. J., Lee, J. H., Lee, H. S., Mun, Y. C., Moon, J. H., Sohn, S. K., Park, S. K., Park, Y., Shin, H. J. & Yoon, S. S., 2018 Jan 1, (Accepted/In press) In : Biology of Blood and Marrow Transplantation.

Research output: Contribution to journalArticle

Busulfan
Melphalan
Stem Cell Transplantation
Multiple Myeloma
Stomatitis
2 Citations (Scopus)

The potential of exosomes derived from chronic myelogenous leukaemia cells as a biomarker

Kang, K. W., Jung, J. H., Hur, W., Park, J., Shin, H., Choi, B., Jeong, H., Kim, D. S., Yu, E. S., Lee, S. R., Sung, H. J., Kim, S. J., Choi, C. W., Kim, H. K., Hong, S., Park, J. H., Choi, Y., Park, Y. & Kim, B. S., 2018 Jul 1, In : Anticancer Research. 38, 7, p. 3935-3942 8 p.

Research output: Contribution to journalArticle

Exosomes
Leukemia, Myelogenous, Chronic, BCR-ABL Positive
Biomarkers
RNA Sequence Analysis
Blast Crisis
2017
2 Citations (Scopus)

BCR-ABL translocation as a favorable prognostic factor in elderly patients with acute lymphoblastic leukemia in the era of potent tyrosine kinase inhibitors

The Korean Adult ALL Working Party & Korean Society of Hematology, 2017 Apr 30, In : Haematologica. 102, 5, p. e187-e190

Research output: Contribution to journalLetter

1 Citation (Scopus)

Can we consider discontinuation of hypomethylating agents in patients with myelodysplastic syndrome: A retrospective study from The Korean Society of Hematology AML/MDS Working Party

The Korean Society of Hematology AML/MDS Working Party, 2017 Jan 1, In : Oncotarget. 8, 45, p. 79414-79424 11 p.

Research output: Contribution to journalArticle

Myelodysplastic Syndromes
Proxy
Hematology
Retrospective Studies
Disease-Free Survival
2 Citations (Scopus)

Clinical outcomes in patients with diffuse large B cell lymphoma with a partial response to first-line R-CHOP chemotherapy: prognostic value of secondary International Prognostic Index scores and Deauville scores

Lee, H., Kim, Y. R., Kim, S. J., Park, Y., Eom, H. S., Oh, S. Y., Kim, H. J., Kang, H. J., Lee, W. S., Moon, J. H., Won, Y. W., Kim, T. S. & Kim, J. S., 2017 Nov 1, In : Annals of Hematology. 96, 11, p. 1873-1881 9 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Drug Therapy
Rituximab
Treatment Failure
Positron-Emission Tomography
1 Citation (Scopus)

Clinicopathological characteristics of extremely young Korean multiple myeloma patients: Therapeutic implications

Shin, J., Koh, Y., Youk, J., Kim, M., Kim, B. S., Choi, C. W., Sung, H. J., Park, Y., Yoon, S. S. & Kim, I., 2017 Jul 1, In : Korean Journal of Internal Medicine. 32, 4, p. 722-730 9 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Therapeutics
Azotemia
Bone and Bones
Hypoalbuminemia
10 Citations (Scopus)

Comprehensive evaluation of the revised international staging system in multiple myeloma patients treated with novel agents as a primary therapy

and the Korean Multiple Myeloma Working Party, 2017 Dec 1, In : American Journal of Hematology. 92, 12, p. 1280-1286 7 p.

Research output: Contribution to journalArticle

Multiple Myeloma
Confidence Intervals
Therapeutics
Thalidomide
Survival
2 Citations (Scopus)
Anthracyclines
Granulocyte Colony-Stimulating Factor
Acute Myeloid Leukemia
Drug Therapy
Chemotherapy-Induced Febrile Neutropenia
4 Citations (Scopus)

Improved prognostic stratification using NCCN- and GELTAMOinternational prognostic index in patients with diffuse large B-cell lymphoma

Hong, J., Kim, S. J., Chang, M. H., Kim, J. A., Kwak, J. Y., Kim, J. S., Yoon, D. H., Lee, W. S., Do, Y. R., Kang, H. J., Eom, H. S., Park, Y., Won, J. H., Mun, Y. C., Kim, H. J., Kwon, J. H., Kong, J. H., Oh, S. Y., Lee, S., Bae, S. H. & 10 others, Yang, D. H., Jun, H. J., Lee, H. S., Yun, H. J., Lee, S. I., Kim, M. K., Yi, J. H., Lee, J. H., Kim, W. S. & Suh, C., 2017 Jan 1, In : Oncotarget. 8, 54, p. 92171-92182 12 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Neoplasms
Survival
Oceans and Seas
Patient Selection
Embryoid Bodies
Pluripotent Stem Cells
8 Citations (Scopus)
Multiple Myeloma
Platelet Count
C-Reactive Protein
Neutrophils
Survival
6 Citations (Scopus)

Platelet to lymphocyte ratio (PLR) retains independent prognostic significance in advanced stage marginal zone lymphoma patients treated with rituximab, cyclophosphamide, vincristine, and prednisone combination chemotherapy (R-CVP): Consortium for Improving Survival of Lymphoma trial

Seo, J., Kim, W. S., Kim, J. S., Kim, S. J., Lee, J. H., Hong, J. S., Lee, G. W., Oh, S. Y., Lee, J. H., Yoon, D. H., Lee, W. S., Kim, H. J., Kwak, J. Y., Kang, H. J., Jo, J. C., Park, Y., Lee, H. S., Kim, H. J. & Suh, C., 2017 Jan 1, In : Blood Research. 52, 3, p. 200-206 7 p.

Research output: Contribution to journalArticle

Vincristine
Prednisone
Combination Drug Therapy
Cyclophosphamide
Lymphoma

Rare case of pulmonary lymphomatoid granulomatosis in conjunction with tuberculosis

Ha, Y. W., Kim, C. H., Park, Y., Sohn, J. W., Min, J. K. & Yoon, Y. K., 2017 Oct 1, In : Medicine (United States). 96, 42, e8323.

Research output: Contribution to journalArticle

Lymphomatoid Granulomatosis
Tuberculosis
Lung
Biopsy
Video-Assisted Thoracic Surgery
2016

A case of atypical hemolytic uremic syndrome associated with the c.1273C > T mutation in the complement C3 gene

Cho, H. J., Kim, J. O., Huh, J. Y., Park, Y., Kim, M-G. & Oh, D., 2016 Jan 1, In : Blood Research. 51, 3, p. 210-213 4 p.

Research output: Contribution to journalLetter

Complement C3
Mutation
Genes
Atypical Hemolytic Uremic Syndrome
90 Citations (Scopus)

A prognostic index for natural killer cell lymphoma after non-anthracycline-based treatment: A multicentre, retrospective analysis

Kim, S. J., Yoon, D. H., Jaccard, A., Chng, W. J., Lim, S. T., Hong, H., Park, Y., Chang, K. M., Maeda, Y., Ishida, F., Shin, D. Y., Kim, J. S., Jeong, S. H., Yang, D. H., Jo, J. C., Lee, G. W., Choi, C. W., Lee, W. S., Chen, T. Y., Kim, K. & 11 others, Jung, S. H., Murayama, T., Oki, Y., Advani, R., d'Amore, F., Schmitz, N., Suh, C., Suzuki, R., Kwong, Y. L., Lin, T. Y. & Kim, W. S., 2016 Mar 1, In : The Lancet Oncology. 17, 3, p. 389-400 12 p.

Research output: Contribution to journalArticle

Natural Killer Cells
Lymphoma
Natural Killer T-Cells
T-Cell Lymphoma
Survival
1 Citation (Scopus)

Assessment of bone marrow involvement in patients with lymphoma: Report on a consensus meeting of the Korean society of hematology lymphoma working party

Park, Y., Park, B. B., Jeong, J. Y., Kim, W. Y., Jang, S. S., Shin, B. K., Lee, D. S., Han, J. H., Park, C. J., Suh, C., Kim, I. & Chi, H. S., 2016 Nov 1, In : Korean Journal of Internal Medicine. 31, 6, p. 1030-1041 12 p.

Research output: Contribution to journalReview article

Hematology
Lymphoma
Bone Marrow
4 Citations (Scopus)

Clinical impact of induction treatment modalities and optimal timing of radiotherapy for the treatment of limited-stage NK/T cell lymphoma

Moon, J. H., Lee, B. H., Kim, J. A., Lee, Y. J., Chae, Y. S., Yhim, H. Y., Kwak, J. Y., Do, Y. R., Park, Y., Song, M. K., Shin, H. J., Kim, T., Lee, J. J. & Yang, D. H., 2016 Oct 1, In : Leukemia Research. 49, p. 80-87 8 p.

Research output: Contribution to journalArticle

T-Cell Lymphoma
Natural Killer Cells
Radiotherapy
Drug Therapy
Therapeutics
8 Citations (Scopus)

Clinical practice guidelines for the management of atypical hemolytic uremic syndrome in Korea

Cheong, H. I., Jo, S. K., Yoon, S. S., Cho, H., Kim, J. S., Kim, Y. O., Koo, J. R., Park, Y., Park, Y. S., Shin, J. I., Yoo, K. H. & Oh, D., 2016 Jan 1, In : Journal of Korean Medical Science. 31, 10, p. 1516-1528 13 p.

Research output: Contribution to journalArticle

Practice Management
Korea
Practice Guidelines
Guidelines
Complement C5
7 Citations (Scopus)
Catenins
Pluripotent Stem Cells
Endoderm
Fibroblast Growth Factor 2
Mesoderm
6 Citations (Scopus)

Cytogenetic profiles of 2806 patients with acute myeloid leukemia—a retrospective multicenter nationwide study

Byun, J. M., Kim, Y. J., Yoon, H. J., Kim, S. Y., Kim, H. J., Yoon, J., Min, Y. H., Cheong, J. W., Park, J., Lee, J. H., Hong, D. S., Park, S. K., Kim, H. J., Ahn, J. S., Shin, H. J., Chung, J. S., Lee, W. S., Lee, S. M., Park, Y., Kim, B. S. & 6 others, Lee, J. H., Lee, K. H., Jung, C. W., Jang, J. H., Min, W. S. & Park, T. S., 2016 Aug 1, In : Annals of Hematology. 95, 8, p. 1223-1232 10 p.

Research output: Contribution to journalArticle

Acute Myeloid Leukemia
Cytogenetics
Multicenter Studies
Chromosome Aberrations
Chromosomes, Human, Pair 7
5 Citations (Scopus)

Highly elevated serum lactate dehydrogenase is associated with central nervous system relapse in patients with diffuse large B-cell lymphoma: Results of a multicenter prospective cohort study

Kim, S. J., Hong, J. S., Chang, M. H., Kim, J. A., Kwak, J. Y., Kim, J. S., Yoon, D. H., Lee, W. S., Do, Y. R., Kang, H. J., Eom, H. S., Park, Y., Won, J. H., Mun, Y. C., Kim, H. J., Kwon, J. H., Kong, J. H., Oh, S. Y., Lee, S., Bae, S. H. & 9 others, Yang, D. H., Jun, H. J., Kim, Y. S., Yun, H. J., Lee, S. I., Kim, M. K., Park, E. K., Kim, W. S. & Suh, C., 2016 Jan 1, In : Oncotarget. 7, 44, p. 72033-72043 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
L-Lactate Dehydrogenase
Cohort Studies
Central Nervous System
Prospective Studies
2 Citations (Scopus)

Induction chemotherapy followed by up-front autologous stem cell transplantation may have a survival benefit in high-risk diffuse large B-cell lymphoma patients

Consortium for Improving Survival of Lymphoma, 2016 Jan 1, In : Experimental Hematology. 44, 1, p. 3-13 11 p.

Research output: Contribution to journalArticle

Induction Chemotherapy
Lymphoma, Large B-Cell, Diffuse
Stem Cell Transplantation
Survival
Survival Rate
3 Citations (Scopus)

Prognostic impact of IPSS-R and chromosomal translocations in 751 Korean patients with primary myelodysplastic syndrome

Suh, K. J., Cheong, J. W., Kim, I., Kim, H. J., Shin, D. Y., Koh, Y., Yoon, S. S., Min, Y. H., Ahn, J. S., Kim, Y. K., Lee, Y. G., Lee, J. O., Bang, S. M., Mun, Y. C., Seong, C. M., Park, Y., Kim, B. S., Hong, J., Park, J., Lee, J. H. & 2 others, Kim, S. Y. & Lee, H. G., 2016 Nov 1, In : PLoS One. 11, 11, e0166245.

Research output: Contribution to journalArticle

Genetic Translocation
Myelodysplastic Syndromes
Survival
Hazards
leukemia
5 Citations (Scopus)

Results of a phase II study of vorinostat in combination with intravenous fludarabine, mitoxantrone, and dexamethasone in patients with relapsed or refractory mantle cell lymphoma: An interim analysis

Shin, D. Y., Kim, S. J., Yoon, D. H., Park, Y., Kong, J. H., Kim, J. A., Kim, B. S., Kim, H. J., Won, J. H., Park, S. K. & Kim, W. S., 2016 Apr 1, In : Cancer Chemotherapy and Pharmacology. 77, 4, p. 865-873 9 p.

Research output: Contribution to journalArticle

Mantle-Cell Lymphoma
Mitoxantrone
Refractory materials
Dexamethasone
Toxicity
1 Citation (Scopus)

The clinical impact of thalidomide maintenance after autologous stem cell transplantation in patients with newly diagnosed multiple myeloma in real clinical practice of Korea

Lee, H. S., Min, C. K., Lee, J. J., Kim, K., Kim, S. J., Yoon, D. H., Eom, H. S., Lee, H., Lee, W. S., Shin, H. J., Lee, J. H., Park, Y., Jo, J. C., Do, Y. R., Mun, Y. C. & Lee, M. H., 2016 May 1, In : Annals of Hematology. 95, 6, p. 911-919 9 p.

Research output: Contribution to journalArticle

Thalidomide
Stem Cell Transplantation
Korea
Multiple Myeloma
Maintenance
4 Citations (Scopus)

The different roles of molecular classification according to upfront autologous stem cell transplantation in advanced-stage diffuse large B cell lymphoma patients with elevated serum lactate dehydrogenase

Kim, Y. R., Kim, S. J., Cheong, J. W., Yang, D. H., Lee, H., Eom, H. S., Sung, Y. O., Kim, H. J., Kang, H. J., Lee, W. S., Park, Y., Yang, W. I., Min, Y. H. & Kim, J. S., 2016 Sep 1, In : Annals of Hematology. 95, 9, p. 1491-1501 11 p.

Research output: Contribution to journalArticle

Lymphoma, Large B-Cell, Diffuse
Hematopoietic Stem Cell Transplantation
Stem Cell Transplantation
L-Lactate Dehydrogenase
Disease-Free Survival
2015
29 Citations (Scopus)

Clinical Outcomes and Prognostic Factors of Up-Front Autologous Stem Cell Transplantation in Patients with Extranodal Natural Killer/T Cell Lymphoma

the Consortium for Improving Survival of Lymphoma Study, 2015 Sep 1, In : Biology of Blood and Marrow Transplantation. 21, 9, p. 1597-1604 8 p.

Research output: Contribution to journalArticle

Natural Killer T-Cells
T-Cell Lymphoma
Stem Cell Transplantation
Survival
Disease-Free Survival
5 Citations (Scopus)
Anthracyclines
Cytarabine
Acute Myeloid Leukemia
Idarubicin
Survival
10 Citations (Scopus)

CXCR2 and its related ligands play a novel role in supporting the pluripotency and proliferation of human pluripotent stem cells

Jung, J. H., Lee, S. J., Kim, J., Lee, S., Sung, H. J., An, J., Park, Y. & Kim, B. S., 2015 Apr 15, In : Stem Cells and Development. 24, 8, p. 948-961 14 p.

Research output: Contribution to journalArticle

Pluripotent Stem Cells
Stem cells
Ligands
Fibroblast Growth Factor 2
Interleukin-8
3 Citations (Scopus)

Imatinib Mesylate Dose Adjustment Based on Body Surface Area for CML Chronic Phase Patients Intolerant to Standard Dosage

Sung, H. J., Lee, S. R., Choi, I. K., Park, Y., Choi, C. W., Kim, H. J., Yhim, H. Y. & Kim, B. S., 2015 Apr 11, (Accepted/In press) In : Acta Haematologica. p. 59-68 10 p.

Research output: Contribution to journalArticle

Leukemia, Myeloid, Chronic Phase
Body Surface Area
Cytogenetics
Imatinib Mesylate
7 Citations (Scopus)

Multicenter analysis of treatment outcomes in adult patients with lymphoblastic lymphoma who received hyper-CVAD induction followed by hematopoietic stem cell transplantation

Jeong, S. H., Moon, J. H., Kim, J. S., Yang, D. H., Park, Y., Cho, S. G., Kwak, J. Y., Eom, H. S., Won, J. H., Hong, J. S., Oh, S. Y., Lee, H. S. & Kim, S. J., 2015 Mar 6, In : Annals of Hematology. 94, 4, p. 617-625 9 p.

Research output: Contribution to journalArticle

Hematopoietic Stem Cell Transplantation
Vincristine
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Doxorubicin
Cyclophosphamide
70 Citations (Scopus)

Nilotinib combined with multiagent chemotherapy for newly diagnosed Philadelphia-positive acute lymphoblastic leukemia

Adult Acute Lymphoblastic Leukemia Working Party of the Korean Society of Hematology, 2015 Aug 6, In : Blood. 126, 6, p. 746-756 11 p.

Research output: Contribution to journalArticle

Chemotherapy
Cell Transplantation
Precursor Cell Lymphoblastic Leukemia-Lymphoma
Residual Neoplasm
Recurrence
3 Citations (Scopus)
Acute Myeloid Leukemia
Drug Therapy
Cytogenetics
Therapeutics
Fever
1 Citation (Scopus)

The prognostic impact of inflammatory factors in patients with multiple myeloma treated with thalidomide in Korea

Kim, C., Lee, H. S., Min, C. K., Lee, J. J., Kim, K., Yoon, D. H., Eom, H. S., Lee, H., Lee, W. S., Shin, H. J., Lee, J. H., Park, Y., Jo, J. C., Do, Y. R. & Mun, Y. C., 2015 Sep 1, In : Korean Journal of Internal Medicine. 30, 5, p. 675-683 9 p.

Research output: Contribution to journalArticle

Thalidomide
Korea
Multiple Myeloma
Induction Chemotherapy
Stem Cell Transplantation
8 Citations (Scopus)

Treatment outcomes of rituximab plus hyper-CVAD in korean patients with sporadic burkitt or burkitt-like lymphoma: Results of a multicenter analysis

Hong, J., Kim, S. J., Ahn, J. S., Song, M. K., Kim, Y. R., Lee, H. S., Yhim, H. Y., Yoon, D. H., Kim, M. K., Oh, S. Y., Park, Y., Mun, Y. C., Do, Y. R., Ryoo, H. M., Lee, J. J., Lee, J. H., Kim, W. S. & Suh, C., 2015 Jan 1, In : Cancer Research and Treatment. 47, 2, p. 173-181 9 p.

Research output: Contribution to journalArticle

Burkitt Lymphoma
Methotrexate
Doxorubicin
Rituximab
Cytarabine
11 Citations (Scopus)

Varicella-zoster virus-specific cell-mediated immunity and herpes zoster development in multiple myeloma patients receiving bortezomib- or thalidomide-based chemotherapy

Kim, J. W., Min, C. K., Mun, Y. C., Park, Y., Kim, B. S., Nam, S. H., Koh, Y., Kwon, J. H., Choe, P. G., Park, W. B. & Kim, I., 2015 Dec 1, In : Journal of Clinical Virology. 73, p. 64-69 6 p.

Research output: Contribution to journalArticle

Human Herpesvirus 3
Thalidomide
Herpes Zoster
Multiple Myeloma
Cellular Immunity